Author details

Full Name

Sharon N Edmiston

Affiliation

ORCID

Career Start Year

1992

Papers

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
37494057	Genetic Variants Associated With Hidradenitis Suppurativa.	JAMA Dermatol	2023
36805567	Methylation of nonessential genes in cutaneous melanoma - Rule Out hypothesis.	Melanoma Res	2023
36926987	Pathway Alterations in Stage II/III Primary Melanoma.	JCO Precis Oncol	2023
37494457	Association of functional, inherited vitamin D-binding protein variants with melanoma-specific death.	JNCI Cancer Spectr	2023
34843679	Characterization of the CpG Island Hypermethylated Phenotype Subclass in Primary Melanomas.	J Invest Dermatol	2022
35876628	Landscape of mutations in early stage primary cutaneous melanoma: An InterMEL study.	Pigment Cell Melanoma Res	2022
34607836	Disease-Associated Risk Variants in <i>ANRIL</i> Are Associated with Tumor-Infiltrating Lymphocyte Presence in Primary Melanomas in the Population-Based GEM Study.	Cancer Epidemiol Biomarkers Prev	2021
33661190	Targeting the IL-2 inducible kinase in melanoma; a phase 2 study of ibrutinib in systemic treatment-refractory distant metastatic cutaneous melanoma: preclinical rationale, biology, and clinical activity (NCI9922).	Melanoma Res	2021
30529013	Identification of a Robust Methylation Classifier for Cutaneous Melanoma Diagnosis.	J Invest Dermatol	2019
30211730	Utility of TERT Promoter Mutations for Cutaneous Primary Melanoma Diagnosis.	Am J Dermatopathol	2019
29753029	Inherited Genetic Variants Associated with Melanoma BRAF/NRAS Subtypes.	J Invest Dermatol	2018
28275920	Breast tumor DNA methylation patterns associated with smoking in the Carolina Breast Cancer Study.	Breast Cancer Research and Treatment	2017
28842324	Associations of MC1R Genotype and Patient Phenotypes with BRAF and NRAS Mutations in Melanoma.	J Invest Dermatol	2017
26146664	Association Between NRAS and BRAF Mutational Status and Melanoma-Specific Survival Among Patients With Higher-Risk Primary Melanoma.	JAMA Oncol	2015
25583948	Body mass index is associated with gene methylation in estrogen receptor-positive breast tumors.	Cancer Epidemiology Biomarkers and Prevention	2015
25809865	Racial variation in breast tumor promoter methylation in the Carolina Breast Cancer Study.	Cancer Epidemiology Biomarkers and Prevention	2015
25934889	IL2 Inducible T-cell Kinase, a Novel Therapeutic Target in Melanoma.	Clin Cancer Res	2015
24986547	DNA methylation profiles in primary cutaneous melanomas are associated with clinically significant pathologic features.	Pigment Cell and Melanoma Research	2014
25287138	DNA methylation profiling in the Carolina Breast Cancer Study defines cancer subclasses differing in clinicopathologic characteristics and survival.	Breast Cancer Research	2014
21375697	DNA-methylation profiling distinguishes malignant melanomas from benign nevi.	Pigment Cell and Melanoma Research	2011
20407015	Altered-function p53 missense mutations identified in breast cancers can have subtle effects on transactivation.	Molecular Cancer Research	2010
20043015	Relationship between germline MC1R variants and BRAF-mutant melanoma in a North Carolina population-based study.		2010
19521985	FAK overexpression and p53 mutations are highly correlated in human breast cancer.	International Journal of Cancer	2009
17553133	Risk factors for breast cancer characterized by the estrogen receptor alpha A908G (K303R) mutation.	Breast Cancer Research	2007
17507627	Number of nevi and early-life ambient UV exposure are associated with BRAF-mutant melanoma.	Cancer Epidemiology Biomarkers and Prevention	2007
16332723	IGF1 CA repeat polymorphisms, lifestyle factors and breast cancer risk in the Long Island Breast Cancer Study Project.	Carcinogenesis	2006
16757721	Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study.	JAMA	2006
16434608	No association between the MDM2 -309 T/G promoter polymorphism and breast cancer in African-Americans or Whites.	Cancer Epidemiology Biomarkers and Prevention	2006
16280033	The estrogen receptor-alpha A908G (K303R) mutation occurs at a low frequency in invasive breast tumors: results from a population-based study.	Breast Cancer Research	2005
15140228	Tandem BRAF mutations in primary invasive melanomas.	Journal of Investigative Dermatology	2004
11784870	RAD1 controls the meiotic expansion of the human HRAS1 minisatellite in Saccharomyces cerevisiae.	Molecular and Cellular Biology	2002
11929815	Prevalence and spectrum of p53 mutations associated with smoking in breast cancer.	Cancer Res	2002
11097232	Dichlorodiphenyldichloroethene, polychlorinated biphenyls, and breast cancer among African-American and white women in North Carolina.	Cancer Epidemiology Biomarkers and Prevention	2000
11303621	Lack of association of rare alleles in the HRAS variable number of tandem repeats (VNTR) region with adult glioma.	Neuro-Oncology	2000
8840997	Internal sequence variations in the Ha-ras variable number tandem repeat rare and common alleles identified by minisatellite variant repeat polymerase chain reaction.	Cancer Res	1996
7612910	Ha-ras rare alleles in breast cancer susceptibility.	Breast Cancer Res Treat	1995
7891670	A cell-based reporter assay for the identification of protein kinase C activators and inhibitors.	Molecular and Cellular Biochemistry	1994
1321443	Coinfection with multiple strains of the Epstein-Barr virus in human immunodeficiency virus-associated hairy leukoplakia.	Proceedings of the National Academy of Sciences of the United States of America	1992